Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-ULBP1 antibody [EPR22088-211] - BSA and Azide free (ab256515)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR22088-211] to ULBP1 - BSA and Azide free
  • Suitable for: Flow Cyt
  • Reacts with: Human

Overview

  • Product name

    Anti-ULBP1 antibody [EPR22088-211] - BSA and Azide free
    See all ULBP1 primary antibodies

  • Description

    Rabbit monoclonal [EPR22088-211] to ULBP1 - BSA and Azide free

  • Host species

    Rabbit

  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    See all applications and species data

  • Immunogen

    Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • Flow: MOLT-4 cells; Human peripheral blood mononuclear cells.

  • General notes

    Ab256515 is the carrier-free version of ab224711. This format is designed for use in antibody labeling, including fluorochromes, metal isotopes, oligonucleotides, enzymes.

     

    Our carrier-free formats are supplied in a buffer free of BSA, sodium azide and glycerol for higher conjugation efficiency.

    Use our conjugation kits  for antibody conjugates that are ready-to-use in as little as 20 minutes with

    ab256515 is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm.

    Maxpar® is a trademark of Fluidigm Canada Inc.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

Images

  • Flow Cytometry - Anti-ULBP1 antibody [EPR22088-211] - BSA and Azide free (ab256515)
    Flow Cytometry - Anti-ULBP1 antibody [EPR22088-211] - BSA and Azide free (ab256515)

    Flow cytometric analysis of Human peripheral blood mononuclear cells (PBMC) labelling ULBP1 with ab224711 at 1/60 dilution (Right) compared with a Rabbit monoclonal IgG (ab172730, Left) isotype control. Goat anti rabbit IgG (Alexa Fluor® 488, ab150097) at 1/5000 dilution was used as the secondary antibody. Cells were stained with rabbit IgG (Left) or ab224711 (Right). Then stained with anti-CD14 conjugated to BV510.  Gated on viable cells.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab224711).

  • Flow Cytometry - Anti-ULBP1 antibody [EPR22088-211] - BSA and Azide free (ab256515)
    Flow Cytometry - Anti-ULBP1 antibody [EPR22088-211] - BSA and Azide free (ab256515)

    Flow cytometric analysis of HaCaT (Human skin keratinocyte, Left) / MOLT-4 (Human lymphoblastic leukemia T lymphoblast, Right) cells labelling ULBP1 with ab224711 at 1/60 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730, Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.

    Negative control: HaCaT. (PMID: 22316211) Gated on viable cells.

    This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab224711).

  • Anti-ULBP1 antibody [EPR22088-211] - BSA and Azide free (ab256515)
    Anti-ULBP1 antibody [EPR22088-211] - BSA and Azide free (ab256515)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-ULBP1 antibody [EPR22088-211] - BSA and Azide free (ab256515)

© 2021 Astana Biomed Group LLP. All rights reserved.